Click here to view this email in your browser.

PERSONAL INVITATION

Mr Wouter DEBEYNE

Flemish Economic Counsellor to Lithuania, Latvia, and Estonia

Has the honour to invite you to

Flanders Life Sciences breakfast Seminar 

Date: 17 May

Time: 8:45 – 11:30

Address:  Gedimino pr. 20, Vilnius, Flanders Investment & Trade,

entrance via Workland business centre

On the occasion of the visit of HE Jan Jambon, Minister-President of the Flanders region, we invite you to join an interactive breakfast seminar on the Life Sciences ecosystem in Flanders. During this session, you will find out about the thriving sector in Flanders, and get first-hand insight into the experiences of 3 Lithuanian companies operating in Belgium.

Agenda

8:45 Doors open  

9:15 Introduction by Flanders Investment & Trade CEO, Claire Tillekaerts 

9:20 Opening speech by HE Minister-President of Flanders Jan Jambon

9:25 Opening speech by Aušrinė Armonaitė, Minister for Economy and Innovation

9:30 Panel discussion with Lithuanian & Belgian companies moderated by Pieter De Maeght, Science & Technology Counselor at Flanders Investment & Trade

10:30 Networking

11:30 Closing of the seminar

Brolis Sensor Technology

Augustinas Vizbaras, CTO and Co-Founder - BROLIS is a high-technology company group developing advanced semiconductor photonic technology for biomedical, industrial and agricultural markets since 2011. In 2017 BROLIS established an R&D office in Ghent, focusing on photonic integrated circuit technology. Later that year they received a Newcomer of the Year award by Flanders Investment and Trade.

Ferentis

Dr. Ramūnas Valiokas, CEO and Co-Founder -  Ferentis is a developer of next-generation biomaterials for emerging biotechnologies and regenerative medicine. Being a small R&D firm, Ferentis is aiming at clinical applications, with ophthalmology being the priority area. Scientists and clinicians at The University and University Hospital of Antwerp have been the strategic partners in this development.

Novosanis

Vanessa Vankerckhoven, CEO and Co-Founder - Novosanis is a Belgian-based medical device company, founded on March 12, 2013, as a spin-off company from the University of Antwerp, Belgium. Novosanis collaborates with Lithuanian founded Diagnolita on innovative solutions in the Life Sciences industry.

Diagnolita

Julius Gagilas, Managing Director - Diagnolita develops innovative cancer and infectious disease diagnostics assays and provides diagnostic services. Diagnolita in collaboration with Novosanis (Belgium) has developed a prostate cancer urine assay with the use of the innovative urine collection device called ColliPee provided by Novosanis.

Kind regards,

EMBASSY OF BELGIUM

Government of Flanders

FLANDERS INVESTMENT & TRADE

T +370 655 43205

vilnius@flanderstrade.com

Gedimino Prospektas 20 | 01103 Vilnius, Lithuania

flandersinvestmentandtrade.com

This is an official e-mail from the Government of Flanders, Belgium

Learn more about our privacy policy

Unsubscribe